Tacrolimus-Induced Cholestatic Hepatitis in a Patient With Liver Transplant

Transplantation. 2018 Oct;102(10):e454-e456. doi: 10.1097/TP.0000000000002332.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Allografts / diagnostic imaging
  • Allografts / drug effects
  • Allografts / pathology
  • Biopsy
  • Carcinoma, Hepatocellular / surgery
  • Carcinoma, Hepatocellular / virology
  • Cholestasis / chemically induced*
  • Cholestasis / diagnostic imaging
  • Cholestasis / pathology
  • Cyclosporine / therapeutic use
  • Graft Rejection / immunology
  • Graft Rejection / prevention & control
  • Hepatitis / diagnostic imaging
  • Hepatitis / etiology*
  • Hepatitis / pathology
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects*
  • Liver / diagnostic imaging
  • Liver / drug effects
  • Liver / pathology
  • Liver Cirrhosis / surgery
  • Liver Cirrhosis / virology
  • Liver Neoplasms / surgery
  • Liver Neoplasms / virology
  • Liver Transplantation / adverse effects*
  • Male
  • Middle Aged
  • Tacrolimus / administration & dosage
  • Tacrolimus / adverse effects*
  • Ultrasonography, Doppler

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Tacrolimus